Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2025-12-26 @ 7:52 AM
Study NCT ID:
NCT05363592
Status:
COMPLETED
Last Update Posted:
2023-01-12
First Post:
2022-04-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers
Sponsor:
Celltrion
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-25
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-19
First Submit QC Date:
None
Study First Post Date:
2022-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-10
Last Update Post Date:
2023-01-12
Last Update Post Date Type:
ACTUAL